Accumulate TCS, breakout can give 60% upside: Analysts

"Historically post-breakout, TCS has given at an average 80% upside; however, due to its large market-cap status, we expect an upside of about 60% leading to a target of ₹6,300," said Dharan Shah, founder, Tradonomy. "Historically on average it has corrected about 25% from the previous top and consolidated timewise for around 2 - 3 years.

Mumbai: looking to accumulate blue-chip stocks could consider Tata Consultancy Services (TCS), India's largest software exporter, at current levels as technical indicators are pointing to a limited downside from here. said by the will be the next big trigger for information technology (IT) stocks, including .

According to , TCS is in an 'uptrend consolidation zone' and is near levels.

"Historically post-breakout, TCS has given at an average 80% upside; however, due to its large market-cap status, we expect an of about 60% leading to a target of ₹6,300," said Dharan Shah, founder, Tradonomy. "Historically on average it has corrected about 25% from the previous top and consolidated timewise for around 2 - 3 years.

In the past three years, TCS shares have hovered in the ₹3,000-4,000 band. On Monday, the stock closed at ₹3,847.65. Shah said an up-move in the stock may not be immediate, but once the hurdle of ₹4,200 levels is breached, there could be sharper upsides.

have fallen out of investors' favour of late on growing uncertainty over the in the US and Europe. So far in 2024, TCS shares have risen 1% while the Nifty IT index shed 4.7%.

"Post the high in March the stock has corrected but the correction has been less compared to the other IT names," said Ruchit Jain, lead research analyst, . "The stock is at its 50% retracement level of ₹3,780 which is a strong support and indicates limited downside in price corrections."

While the stock is not at its breakout level yet, the downside is limited, he said. Analysts said the lack of clarity about the timing of the interest rate cuts in the US will cap upsides in the near term. "The is expecting an interest rate cut by the US Fed which is why the downside in IT stocks such as TCS is limited," said Jain. "However, once there is some clarity and certainty on when the US Fed is expected to cut interest rates, IT stocks are expected to rally, after brief consolidation."
Accumulate TCS, Breakout Can Give 60% Upside: AnalystsAgencies

Staggered buying
"If the Nifty IT index moves up, then TCS is expected to outperform since the correction in the stock has been lesser compared to its peers, indicating relative strength," said Jain. "IT sector has not contributed much to the recent upswing in the markets and investors can choose to buy TCS in a staggered manner till ₹3,700 levels."


Source: Stocks-Markets-Economic Times

Последние публикации
Investors "discounting" Google's possible loss of Apple search deal - Oppenheimer
25.09.2024 - 18:00
Apple stock: New Street Research sees a 10% miss on iPhone 16 shipments
25.09.2024 - 18:00
Cintas earnings beat by $0.10, revenue topped estimates
25.09.2024 - 18:00
Explainer-California says Exxon's recycling claims created a 'public nuisance.' What does that mean?
25.09.2024 - 18:00
BBVA CEO remains bullish on Mexico ahead of presidential transition
25.09.2024 - 18:00
Merrill Lynch, Harvest Volatility Management to pay $9.3 million to settle SEC charges
25.09.2024 - 18:00
Southwest plans to reduce service and staffing in Atlanta, union says
25.09.2024 - 18:00
NVIDIA, Flutter and HPE lead morning market cap stock movers on Wednesday
25.09.2024 - 18:00
FTC announces crackdown on deceptive AI claims and schemes
25.09.2024 - 18:00
Southwest plans to reduce Atlanta service, cut some jobs, union says
25.09.2024 - 17:00
Germany turns up heat on UniCredit as Orcel urges talks over Commerzbank
25.09.2024 - 17:00
Google: Signs that enterprise adoption of AI Is inflecting, says JMP Securities
25.09.2024 - 16:00
UniCredit overtures hold few fears for Germany's Mittelstand
25.09.2024 - 16:00
Hewlett Packard Enterprise upgraded to "Overweight" by Barclays
25.09.2024 - 16:00
Obesity drug developer BioAge Labs aims up to $640 million valuation in upsized US IPO
25.09.2024 - 16:00

© Analytic DC. All Rights Reserved.

new
Обзор рынка ЗАПАСЫ СЫРОЙ НЕФТИ В США -4,471М
Добро пожаловать в чат поддержки!
*
*

Ваш запрос успешно отправлен!
Скоро с вами свяжутся.